Bibliography
- Lopez Ad, Murray CC. The global burden of disease: 1990 – 2020. Nat Med 1998;4:1241-3
- Tengattini S, Reiter RJ, Tan DX, Cardiovascular diseases: protective effects of melatonin. J Pineal Res 2008;44:16-25
- Petrosillo G, Di Venosa N, Pistolese M, Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia- reperfusion: role of cardiolipin. FASEB J 2006;20:269-76
- Papaharalambus CA, Griendling KK. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 2007;17:48-54
- Alvarez Y, Pérez-Girón JV, Hernanz R, Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats. J Pharmacol Exp Ther 2007;321:381-8
- Nava M, Quiroz Y, Vaziri N, Rodriguez-Iturbe B. Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 2003;284:F447-54
- Takimoto E, Kass DA. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 2007;49:241-8
- Dominguez-Rodriguez A, Abreu-Gonzalez P, Arroyo-Ucar E, Reiter RJ. Decreased level of melatonin in serum predicts left ventricular remodelling after acute myocardial infarction. J Pineal Res 2012; in press
- Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011;51:1-16
- Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P. The role of melatonin in acute myocardial infarction. Front Biosci 2012;17:2433-41
- Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ. Melatonin and cardiovascular disease: myth or reality? Rev Esp Cardiol 2012;65:215-18
- Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 2010;49:14-22
- Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ. Clinical aspects of melatonin in the acute coronary syndrome. Curr Vasc Pharmacol 2009;7:367-73
- Reiter RJ, Tan DX, Paredes SD, Fuentes-Broto L. Beneficial effects of melatonin in cardiovascular disease. Ann Med 2010;42:276-85
- Lee YM, Chen HR, Hsiao G, Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res 2002;33:72-80
- Kilic U, Yilmaz B, Ugur M, Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia. J Pineal Res 2012;52:228-35
- Dubocovich ML, Delagrange P, Krause DN, International union of basic and clinical pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 2010;62:343-80
- Hardeland R. Investigational melatonin receptor agonists. Expert Opin Investig Drugs 2010;19:747-64